# The modified 30-second chair stand test (m-30s-CST) is more sensitive than handgrip strength in detecting muscle strength changes and predicting physical performance in hospitalized geriatric patients

**Authors:** Walther M. W. H. Sipers, Martijn J.A. Rothbauer, Isis Ensink, Shannon Röhlinger, Audrey H.H. Merry, Francesco Curcio, Francesco Curcio, Francesco Curcio

PMC · DOI: 10.1371/journal.pone.0331155 · PLOS One · 2026-03-16

## TL;DR

A modified chair stand test is better than handgrip strength for measuring muscle strength and predicting outcomes in elderly hospitalized patients.

## Contribution

The modified 30-second chair stand test is shown to be more sensitive than handgrip strength in detecting muscle strength changes and predicting mortality.

## Key findings

- The m-30s-CST showed significant changes in patients who improved in physical performance, unlike handgrip strength.
- Patients with fewer than 6 m-30s-CST repetitions had higher two-year mortality.
- The m-30s-CST had a trend toward predicting two-year mortality, while handgrip strength did not.

## Abstract

To compare the modified-30s-Chair-Stand-Test (m-30s-CST) with handgrip strength (HGS) in measuring muscle strength in acutely ill geriatric patients. The aim of this study was to compare the responsiveness and predictive value of the m-30s-CST and HGS for physical performance and two-year mortality in hospitalized geriatric patients.

Responsiveness of the m-30s-CST and HGS was assessed in 92 patients (mean age 84 ± 6 years, 53.5% female) by comparing the performance at hospital admission and the day before discharge. These changes were then compared with changes in the ADL-Barthel-Index (ADL-BI) and Short Physical Performance Battery (SPPB).

The number of repetitions on the m-30s-CST increased significantly during hospitalization in patients who improved on ADL-BI (n = 43) and SPPB (n = 33) and did not change in those who remained stable or worsened (ADL-BI: n = 32 and SPPB: n = 26). There was no significant change in HGS in either patients who improved on respectively ADL-BI (n = 43) and SPPB (n = 41), nor in those who remained stable or worsened (ADL-BI: n = 31 and SPPB: n = 34). The m-30s-CST showed a trend towards prediction of two-year mortality (AUC 0.609; P = 0,071) while HGS did not (AUC 0.573; P = 0.221). Two-year mortality was significantly higher in geriatric patients (n = 92) with less than 6 repetitions compared with patients with more than 5 repetitions on the m-30s-CST (HR 2.739; CI-95%: 1.173–6.396; P = 0.020). HGS according the EWGSOP-2 criteria was not associated with 2-year mortality (HR 0.969; CI-95%: 0.495–1.900; P = 0.928).

The m-30s-CST is superior to HGS for assessing changes in muscle strength and serves as a better proxy for physical performance, and is probably a predictor of two-year mortality in hospitalized geriatric patients.

## Full-text entities

- **Genes:** CST12P (cystatin 12, pseudogene) [NCBI Gene 106478911] {aka Cst, Ctes4, E2}, HGS (hepatocyte growth factor-regulated tyrosine kinase substrate) [NCBI Gene 9146] {aka HRS}
- **Diseases:** Frailty (MESH:D000073496), terminally ill (MESH:D007153), falls (MESH:C537863), Malnutrition (MESH:D044342), death (MESH:D003643), Sarcopenia (MESH:D055948), Comorbidity (MESH:D004194), delirium (MESH:D003693), CCI (MESH:C566784), metabolic syndrome (MESH:D024821), Catabolic syndrome (MESH:D013577), inflammation (MESH:D007249)
- **Chemicals:** Curcio (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12991214/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12991214/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12991214/full.md

---
Source: https://tomesphere.com/paper/PMC12991214